Search Results

You are looking at 171 - 180 of 1,090 items for :

  • "community" x
  • Refine by Access: All x
Clear All
Full access

Move It!

Margaret Tempero

level of activity, we could expect a significant reduction in cancer incidence. So, what does this mean for the professional oncology community? The public and even other health care professionals look to us for guidance about cancer prevention. We

Full access

Getting Practical About Recertification

Margaret Tempero

have come to admire my colleagues in community practice for their ability to deliver the highest possible care for patients with cancer. They don't have the luxury of focusing on just one disease or a group of diseases. They must be fluent in the

Full access

All Bundled Up!

Margaret Tempero

This is going to be interesting, but we knew it was coming. Ever since the passage of the Affordable Care Act, health economists were predicting it. Large health maintenance organizations are looking forward to it. Community oncologists are

Full access

Introduction: Addressing Challenges in Multiple Myeloma Management in an Era of New Therapeutics

Sundar Jagannath

experts via a roundtable discussion held April 24, 2009, in Philadelphia. Our charge was to develop outlines of 10 articles about myeloma therapy that would convey the information currently of most importance to community oncologists. The first 2 of the 4

Full access

BIO24-032: Early Diagnosis of Cancer Cachexia Using Body Composition Index as the Radiographic Biomarker

Sabeen Ahmed, Nathan Parker, and Ghulam Rasool

networks (DNNs). However, the lack of reproducibility remains a prominent concern, primarily attributed to the absence of a publicly shared code. This limitation hinders the scientific community's ability to validate and build upon existing research in this

Full access

EPR24-106: Sociodemographic Trends and Regional Disparities Associated With Leukemia in Florida: Implications of an Aging-Population on Leukemia Incidences and Mortalities in the United States

Ming Lee, Rebecca Kaiser, Christopher Armstrong, Nancy Elliott, Justin Taylor, Raymond Balise, and Erin Kobetz

moved and settled in Florida from these six states every year. Regions in Florida with the highest leukemia incidences and mortalities all contain many retirement communities. Conclusions: The results of this study suggest that Florida’s leukemia

Full access

HSR20-085: Real-World Study of Factors Associated With Breast Conserving Surgery for Females Diagnosed With Early Stage Breast Cancer

Judy George, Joseph Tkacz, M. Christopher Roebuck, Fredy Reyes, Yull E. Arriaga, Gretchen P. Jackson, and Irene Dankwa-Mullan

, and comorbid conditions, 2) community-level (ZIP3) measures from 2019 Area Health Resource Files, and 3) time effects. Results: A total of 57,299 patients were included. Higher BCS use (versus mastectomy) was significantly associated with: more

Full access

HSR20-100: Results From a Pilot Study Examining the Impact of Distress Screening and Referral on Cancer Patient Cost and Health Care Utilization

Melissa F. Miller, Melyssa Allen, Diane Robinson, Nicole Nicksic, and Alexandra Zaleta

Background: The Cancer Support Community (CSC) has investigated screening, referral and follow-up for cancer-related distress through the CancerSupportSource® (CSS) since 2008. The impact of CSS on patient cost and health care utilization at a

Full access

HSR20-078: Cancer Patients and Family Caregivers as a Unit of Care

Hui Ling Chen and Tsui-Sui Annie Annie Kao

an evidence-based research into practice at the local community and examine the effects of cancer patients and their caregivers’ self-efficacy, coping, and quality of life by using Northouse’s FOCUS program, a rigorously tested nurse

Full access

HSR22-141: Treatment Patterns and Clinical Outcomes Among Metastatic Non-Small Cell Lung Cancer Patients Without Actionable Genomic Alterations (AGAs) Previously Treated With Platinum-Based Chemotherapy and Immunotherapy

Jerome H Goldschmidt, Anupama Vasudevan, Michelle Silver, Jackie Kwong, and Elizabeth Marrett

is the standard of care (SOC). However, there is little real-world data on subsequent treatment (sTx) after plat and IO discontinuation. This study characterized sTx in mNSCLC patients without AGAs in US community oncology practices. Methods : This